Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. May 21, 2014; 20(19): 5760-5772
Published online May 21, 2014. doi: 10.3748/wjg.v20.i19.5760
Published online May 21, 2014. doi: 10.3748/wjg.v20.i19.5760
Child’s status | Treatment |
A | Two hepatotoxic drugs can be used namely isoniazid and rifampicin with/without pyrazinamide (low dose). Duration 6-9 mo |
B | Ideally one hepatotoxic drug is used in combination. Pyrazinamide generally avoided Duration generally 9-12 mo |
C | No hepatotoxic drugs to be used. Can use second-line drugs like streptomycin, ethambutol, fluoroquinolones, amikacin, kanamycin for extended duration of 12 mo or more. Role of aminoglycosides may be limited due to reduced renal reserve in these patients |
- Citation: Kumar N, Kedarisetty CK, Kumar S, Khillan V, Sarin SK. Antitubercular therapy in patients with cirrhosis: Challenges and options. World J Gastroenterol 2014; 20(19): 5760-5772
- URL: https://www.wjgnet.com/1007-9327/full/v20/i19/5760.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i19.5760